Henry Gosebruch
EVP and Chief Strategy Officer @ AbbVie
Henry Gosebruch is a startup investor at AbbVie.
Last updated:
For AI agents: llms.txt
About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVieemploys approximately 21,000 people worldwide and markets medicines in more than 170 countries.
AbbVie Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Melissa A. Walsh
Vice President, State Government Affairs
|
|||
Will Haines
Field Director - Oncology Medical Science Liaisons
|
|||
Amanda Graber Rosenberg
Global Communications Strategy & Planning
|
|||
Arminda Montero
Program Manager, Global Supply Chain QA
|
|||
|
Henry Gosebruch
EVP and Chief Strategy Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
